This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Licinio J et al. Mol Psychiatr 2002; 7: 1031–1032.
Raikkonen K et al. Metabolism 2002; 51: 1573–1577.
Bonnet F et al. J Hypertens 2005; 23: 611–617.
Kishi T, Elmquist JK . Mol Psychiatr 2005; 10: 132–146.
Licinio J, Wong ML . Rev Bras Psiquiatr 2003; 25: 196–197.
Sima AA, Li ZG . Diabetes 2005; 54: 1497–1505.
Benedict C et al. Psychoneuroendocrinology 2004; 29: 1326–1334.
Kern W et al. Diabetes 1990; 39: 1091–1098.
Herrmann C . J Psychosom Res 1997; 42: 17–41.
Berlin I et al. J Clin Endocrinol Metab 1994; 79: 1428–1433.
Buysschaert M et al. Diabetes Metab 1988; 14: 75–79.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reichel, A., Schwarz, J., Schulze, J. et al. Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII). Mol Psychiatry 10, 975–976 (2005). https://doi.org/10.1038/sj.mp.4001726
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001726
This article is cited by
-
Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders
Molecular Neurobiology (2013)
-
Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives
The Pharmacogenomics Journal (2009)